Published in J Pharm Biomed Anal on April 14, 1994
Simultaneous identification and quantification of canrenone and 11-α-hydroxy-canrenone by LC-MS and HPLC-UVD. J Biomed Biotechnol (2011) 0.77
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Hypothermia and thermoregulatory derangements induced by valproic acid. Neurology (2000) 1.64
Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.57
Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res (1997) 1.54
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J (1990) 1.49
Spontaneous dissection of native coronary arteries. Heart (2005) 1.41
Optimal stent positioning in coronary arteries: partial balloon inflation to overcome cardiac cycle-related motion of the stent/delivery system. Catheter Cardiovasc Interv (2000) 1.39
Chlorpromazine & appetite. J Am Geriatr Soc (1991) 1.38
Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation (1992) 1.38
Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin Pharmacol Ther (1985) 1.20
Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol (1981) 1.07
Determination of arginine and methylated arginines in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.99
Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2000) 0.98
HPLC determination of guaifenesin with selected medications on underivatized silica with an aqueous-organic mobile phase. J Pharm Biomed Anal (2000) 0.98
Idiopathic dilated cardiomyopathy. BMJ (1990) 0.97
Improved sample extraction before liquid chromatography of prednisone and prednisolone in human serum. Clin Chem (1982) 0.97
Stent longitudinal flexibility: a comparison of 13 stent designs before and after balloon expansion. Catheter Cardiovasc Interv (2000) 0.97
Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol (1978) 0.95
Carbamazepine treatment of a patient with Klüver-Bucy syndrome. J Clin Psychiatry (1985) 0.93
Akathisia following traumatic brain injury: treatment with bromocriptine. J Neurol Neurosurg Psychiatry (1989) 0.93
Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun (1990) 0.91
Comparison of coronal bacterial leakage between immediate versus delayed post-space preparation in root canals filled with Resilon/Epiphany. Int Endod J (2009) 0.90
A randomized study of direct coronary stent delivery compared with stenting after predilatation: the NIR future trial. On behalf of the NIR Future Trial Investigators. Catheter Cardiovasc Interv (2000) 0.89
HPLC-photolysis-electrochemical detection in pharmaceutical analysis: application to the determination of spironolactone and hydrochlorothiazide in tablets. J Chromatogr Sci (1990) 0.88
Stent deformation following simulated side-branch dilatation: a comparison of five stent designs. Catheter Cardiovasc Interv (1999) 0.86
Surgical specialties affect scheduling. Hospitals (1971) 0.84
Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease. J Clin Psychopharmacol (1990) 0.84
Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol (1977) 0.83
Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives. J Pharm Biomed Anal (2000) 0.83
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4 degrees C. Am J Health Syst Pharm (1996) 0.83
In vitro and in vivo bioequivalence of commercial prednisone tablets. Biopharm Drug Dispos (1985) 0.83
Colorimetric determination of isoniazid with 9-chloroacridine. J Pharm Sci (1975) 0.82
Fluorometric determination of chlorzoxazone in tablets and biological fluids. J Pharm Sci (1979) 0.82
Paradoxical aggressive effect of propranolol in a patient with Huntington's disease. J Clin Psychiatry (1987) 0.81
Determination of ondansetron and its hydroxy metabolites in human serum using solid-phase extraction and liquid chromatography/positive ion electrospray tandem mass spectrometry. J Mass Spectrom (2000) 0.80
Analysis of clonazepam in a tablet dosage form using smallbore HPLC. J Pharm Biomed Anal (1998) 0.80
Meperidine metabolites: identification of N-hydroxynormeperidine and a hydroxy-methoxy derivative of meperidine in biological fluids. Res Commun Chem Pathol Pharmacol (1976) 0.80
Aggressive behavior in Huntington's disease: treatment with propranolol. J Clin Psychiatry (1987) 0.80
Probing pair-correlated fermionic atoms through correlations in atom shot noise. Phys Rev Lett (2005) 0.80
High-performance liquid chromatography with electrochemical detection of chlorzoxazone and its hydroxy metabolite in serum using solid-phase extraction. J Chromatogr (1986) 0.80
Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc (2001) 0.80
Determination of degradation products from the calcium-channel blocker isradipine. J Pharm Biomed Anal (1998) 0.79
Solution conformation of model polypeptides with the use of particle beam LC/FT-IR spectrometry and electrospray mass spectrometry. J Pharm Biomed Anal (1999) 0.79
Evolution of the normal state of a strongly interacting Fermi gas from a pseudogap phase to a molecular Bose gas. Phys Rev Lett (2011) 0.79
Fluorescent analysis of primary aliphatic amines by reaction with 9-isothiocyanatoacridine. J Pharm Sci (1971) 0.79
Determination of methyldopa in pharmaceutical dosage forms and biological fluids based on oxidation at the tubular carbon electrode. J Pharm Sci (1974) 0.79
Treatment of Huntington's disease with clonazepam. South Med J (1988) 0.78
Determination of degradation products of sumatriptan succinate using LC-MS and LC-MS-MS. J Pharm Biomed Anal (2001) 0.78
Assay for the simultaneous determination of acetaminophen-caffeine-butalbital in human serum using a monolithic column. J Pharm Biomed Anal (2004) 0.78
Comparative intraoperative concentrations of two cephalosporins with activity against anaerobic bacteria. J Antimicrob Chemother (1989) 0.78
Separation of non-steroidal anti-inflammatory agents using supercritical fluid chromatography. J Chromatogr (1992) 0.78
Determination of clonidine in human plasma by cold on-column injection capillary gas chromatography-selected-ion monitoring-mass spectrometry. J Chromatogr (1988) 0.78
Ibuprofen-induced lithium toxicity. South Med J (1989) 0.78
Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2001) 0.77
Paroxetine treatment of sexual disinhibition in dementia. Am J Psychiatry (1997) 0.77
Solution conformation of model peptides with the use of particle beam LC/FT-IR spectrometry and electrospray mass spectrometry. J Pharm Biomed Anal (1998) 0.77
Validation of bedside measurements of absolute human renal blood flow by a continuous thermodilution technique. Crit Care Med (1992) 0.77
Treatment of coprophagia with carbamazepine. Am J Psychiatry (1995) 0.77
A case of mania associated with high-dose baclofen therapy. J Clin Psychopharmacol (1992) 0.76
A liquid chromatographic method for the determination of promethazine enantiomers in human urine and serum using solid-phase extraction and fluorescence detection. J Pharm Biomed Anal (1995) 0.76
Ticlopidine induced agranulocytosis managed with granulocyte colony stimulating factor. N Z Med J (1998) 0.76
Quantitation of trimipramine enantiomers in human serum by enantioselective high-performance liquid chromatography and mixed-mode disc solid-phase extraction. J Chromatogr B Biomed Sci Appl (1997) 0.76
Quantitative GLC determination of pentylenetetrazol in biological fluids. J Pharm Sci (1975) 0.76
Plasma levels of clobazam after 10-, 20-, and 40-mg tablet doses in healthy subjects. J Clin Pharmacol (1980) 0.75
Posttraumatic stress disorder and partial complex seizures. Am J Psychiatry (1986) 0.75
Mitral valve and wedge pressure. Lancet (1989) 0.75
Adult coronary artery disease secondary to childhood Kawasaki disease. Lancet (1992) 0.75
Treatment of hypotension in septic shock. Lancet (1996) 0.75
A progressive pericardial effusion caused by psittacosis. Br Heart J (1988) 0.75
Severe lithium toxicity associated with indapamide therapy. J Clin Psychopharmacol (1990) 0.75
A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form. J Pharm Biomed Anal (1995) 0.75
A high performance liquid chromatographic method for the determination of albuterol enantiomers in human serum using solid phase extraction and chemical derivatization. Biomed Chromatogr (1993) 0.75
Supercritical fluid extraction of selected pharmaceuticals from water and serum. J Chromatogr B Biomed Sci Appl (1997) 0.75
Stability of mupirocin ointment (Bactroban) admixed with other proprietary dermatological products. J Clin Pharm Ther (1992) 0.75
A case of early-onset Pick's disease. J Clin Psychiatry (1992) 0.75
Thickness-shear mode shapes and mass-frequency influence surface of a circular and electroded AT-cut quartz resonator. IEEE Trans Ultrason Ferroelectr Freq Control (1992) 0.75
Determination of sulindac and its metabolites in human serum by reversed-phase high-performance liquid chromatography using on-line post-column ultraviolet irradiation and fluorescence detection. J Chromatogr B Biomed Appl (1995) 0.75
Chromatographic analysis of selected tetracyclines from dosage forms and bulk drug substance using polymeric columns with acidic mobile phases. J Pharm Biomed Anal (1994) 0.75
Separation of tetracyclines by liquid chromatography with acidic mobile phases and polymeric columns. J Pharm Biomed Anal (1993) 0.75
HPLC separation of pentazocine enantiomers in serum using an ovomucoid chiral stationary phase. Biomed Chromatogr (1995) 0.75
Supercritical fluid chromatography of selected oestrogens. J Pharm Biomed Anal (1992) 0.75
A comparison of disc and cartridge solid-phase extraction for the LC determination of rifampin and 25-desacetylrifampin in human serum. J Pharm Biomed Anal (1995) 0.75
Acute changes in atrial natriuretic peptide, insulin-like growth factor-1, and lactate levels during left anterior descending coronary artery angioplasty. Am Heart J (1995) 0.75
Huntington's disease and propranolol. Am J Psychiatry (1993) 0.75
High-performance liquid chromatographic separation of ondansetron enantiomers in serum using a cellulose-derivatized stationary phase and solid-phase extraction. J Chromatogr (1993) 0.75
Stereoselective determination of apomorphine enantiomers in serum with a cellulose-based high-performance liquid chromatographic chiral column using solid-phase extraction and ultraviolet detection. J Chromatogr B Biomed Appl (1996) 0.75
Liquid chromatographic separation of praziquantel enantiomers in serum using a cellulose-based chiral stationary phase. J Pharm Biomed Anal (1994) 0.75
Stereoselective determination of R(-)- and S(+)-prilocaine in human serum using a brush-type chiral stationary phase, solid-phase extraction and UV detection. J Pharm Biomed Anal (1996) 0.75
Prolongation of ECT-induced seizures with theophylline. J Am Geriatr Soc (1996) 0.75
High-performance liquid chromatographic analysis of pindolol enantiomers in human serum and urine using a reversed-phase cellulose-based chiral column. J Chromatogr B Biomed Appl (1995) 0.75
Recovery of digoxin and related glycosides from an injection dosage form by liquid-liquid and solid-phase extraction. J Pharm Biomed Anal (1994) 0.75
Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections. J Clin Pharm Ther (1994) 0.75
Differential protein binding of ceftizoxime in cord versus maternal serum. Am J Obstet Gynecol (1993) 0.75
Analysis of chlortetracycline by high performance liquid chromatography with postcolumn alkaline-induced fluorescence detection. Biomed Chromatogr (1993) 0.75
High-performance thin-layer chromatographic determination of digoxin and related compounds, digoxigenin bisdigitoxoside and gitoxin, in digoxin drug substance and tablets. J Chromatogr A (1994) 0.75
Determination of fenbufen and its metabolites in serum by reversed-phase high-performance liquid chromatography using solid-phase extraction and on-line post-column ultraviolet irradiation and fluorescence detection. J Chromatogr B Biomed Appl (1996) 0.75
Case management in Alzheimer's disease. J Case Manag (1993) 0.75
Determination of metronidazole in vaginal tissue by high-performance liquid chromatography using solid-phase extraction. J Chromatogr B Biomed Appl (1995) 0.75
Treatment of organic hallucinosis with carbamazepine. Am J Psychiatry (1995) 0.75
Stereoselective determination of mepivacaine in human serum using a brush-type chiral stationary phase and solid-phase extraction. J Chromatogr B Biomed Sci Appl (1997) 0.75